EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Retinol Binding Protein 4 and Uric Acid as Risk Factors for Insulin Resistance in Type 2 Diabetes Mellitus

Linyan Cheng iD, Liyan Wu iD, Tao-Hsin Tung iD, Zijun Chai iD, Yufen Zheng iD, Bo Shen iD

Journal of Diabetes Research · 2026-01 · 2026 (1)

DOI: 10.1155/jdr/9446806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, online erschienen am 08.06.2026. Verfasst von Linyan Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China, wmu.edu.c…. Hauptthemen laut MEDLINE: Retinol-Binding Proteins, Plasma, Diabetes Mellitus, Type 2, Insulin Resistance, Uric Acid. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Foundation of Taizhou Enze Medical Center (Group), Science and Technology Plan Project of Taizhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperuricemia (HUA) is closely associated with insulin resistance (IR). Retinol‐binding protein 4 (RBP4) plays a critical role in inducing IR. However, the combined effects of uric acid (UA) and RBP4 on IR remain unclear. This study aimed to identify the risk factors for IR in type 2 diabetes mellitus (T2DM) patients and to investigate the potential relationship between UA and RBP4 in this context.

Methods

This study included 570 patients aged 18–60 years with T2DM who were treated at Taizhou Hospital in Zhejiang Province. Univariate and multivariate logistic regression analyses were performed to evaluate the associations of UA and RBP4 levels with IR risk in T2DM patients. Mediation analysis was conducted to assess the mediating role of RBP4 in the relationship between UA and homeostasis model assessment of insulin resistance (HOMA‐IR). Finally, ROC curve analysis was performed to examine the evaluation value of the model for IR in patients with T2DM.

Results

RBP4 and UA levels were significantly correlated with HOMA‐IR ( p < 0.01). Mediation analysis revealed that RBP4 partially mediated the relationship between UA and IR ( p < 0.05, with the mediating effect accounting for 23.2%). Furthermore, both RBP4 and UA were identified as significant risk factors for IR in patients with T2DM ( p < 0.05). The risk of IR associated with HUA was greater when RBP4 ≥ 36.6 mg/L ( p < 0.001). The ROC analysis showed that compared with UA or RBP4 alone, the combination of RBP4 and UA was more effective in detecting IR and represented a superior assessment model (AUC = 0.788, p < 0.001).

Conclusions

RBP4 played a partial mediating role between UA and IR. Both RBP4 and UA were risk factors for IR in T2DM patients. The combined use of these two indicators can better evaluate the risk of IR. Further research is needed to validate the reliability of using UA and RBP4 levels to evaluate IR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinol-Binding Proteins, PlasmaDiabetes Mellitus, Type 2Insulin ResistanceUric AcidHyperuricemiaHumansMiddle AgedFemaleMaleRisk FactorsAdultYoung AdultAdolescentBiomarkersChinaROC CurveBlood Glucose

Stichwörter der Autor:innen

hyperuricemiainsulin resistanceretinol-binding protein 4type 2 diabetes mellitus

Substanzen

Retinol-Binding Proteins, PlasmaRBP4 protein, humanUric AcidBiomarkersBlood Glucose

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China, wmu.edu.cn.
  • Key Laboratory of System Medicine and Precision Diagnosis and Treatment of Taizhou, Taizhou, Zhejiang, China.
  • Clinical Laboratory, Dongyang People's Hospital, Dongyang, Zhejiang, China, dyhospital.com.
  • Evidence-Based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China, wmu.edu.cn.

ORCID-Profile: Linyan Cheng, Liyan Wu, Tao-Hsin Tung, Zijun Chai, Yufen Zheng, Bo Shen

Förderung

  • Scientific Research Foundation of Taizhou Enze Medical Center (Group)
  • Science and Technology Plan Project of Taizhou

Zitieren

APA

Cheng, L., Wu, L., Tung, T. H., Chai, Z., Zheng, Y., & Shen, B. (2026). Retinol Binding Protein 4 and Uric Acid as Risk Factors for Insulin Resistance in Type 2 Diabetes Mellitus. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/9446806

Vancouver

Cheng L, Wu L, Tung TH, Chai Z, Zheng Y, Shen B. Retinol Binding Protein 4 and Uric Acid as Risk Factors for Insulin Resistance in Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/9446806

BibTeX
@article{Cheng2026,
  author = {Cheng, Linyan and Wu, Liyan and Tung, Tao-Hsin and Chai, Zijun and Zheng, Yufen and Shen, Bo},
  title = {Retinol Binding Protein 4 and Uric Acid as Risk Factors for Insulin Resistance in Type 2 Diabetes Mellitus},
  journal = {Journal of Diabetes Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jdr/9446806}
}
Kostenlos starten →